obesity drug news today glp-1 september 29 2025 President Trump announced that Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for weight management indications for people with obesity. Our senior staff writer Kristen Monaco GLP-1 Agonists Weight Loss Drugs

However, many people don't get enough from their diets

Tirzepatide, sold as Mounjaro, is a different molecule from Eli Lilly and is not part of this Semaglutide patent expiry story

Diabetic complications, pancreatic inflammation, and severe heart muscle weakness: In a 56-year-old woman with a complex medical history and whose outpatient medication had not been adjusted in the last 3 years

Paired with MOTS-c, a mitochondrial peptide that enhances metabolism, stamina, and exercise performance, this stack helps optimize weight management and energy from the inside out

The overall GLP-1 class maintains a 5-10% discontinuation rate, which compares favorably to many other chronic disease medications ^6

Price: We included options to suit a variety of budgets